<div class="WordSection1">
<p class="RegularParagraphs"><b> §329D-10 Types of manufactured cannabis products. </b>(a) The types of medical cannabis products that may be manufactured and distributed pursuant to this chapter shall be limited to:</p>
<p class="1Paragraph"> (1) Capsules;</p>
<p class="1Paragraph"> (2) Lozenges;</p>
<p class="1Paragraph"> (3) Pills;</p>
<p class="1Paragraph"> (4) Oils and oil extracts;</p>
<p class="1Paragraph"> (5) Tinctures;</p>
<p class="1Paragraph"> (6) Ointments and skin lotions;</p>
<p class="1Paragraph"> (7) Transdermal patches;</p>
<p class="1Paragraph"> (8) Pre-filled and sealed containers used to aerosolize and deliver cannabis orally, such as with an inhaler or nebulizer; and</p>
<p class="1Paragraph"> (9) Other products as specified by the department.</p>
<p class="RegularParagraphs"> (b) As used in this section, "lozenge" means a small tablet manufactured in a manner to allow for the dissolving of its medicinal or therapeutic component slowly in the mouth. [L 2015, c 241, pt of §2; am L 2016, c 230, §17; am L 2017, c 170, §2]</p>
<p class="RegularParagraphs"></p>
<p class="XNotesHeading">Revision Note</p>
<p class="XNotes"></p>
<p class="XNotes"> In subsection (a)(8), "marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.</p>
<p class="RegularParagraphs"></p>
<p class="RegularParagraphs"></p>
</div>